Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Capital Expenditures (2023 - 2026)

Kura Oncology has reported Capital Expenditures over the past 4 years, most recently at $128000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 56.16% to $128000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Mar 2026, up 852.06% year-over-year, with the annual reading at $6.6 million for FY2025, 1306.36% up from the prior year.
  • Capital Expenditures was $128000.0 for Q1 2026 at Kura Oncology, down from $4.6 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $4.6 million in Q4 2025 and troughed at $16000.0 in Q4 2023.
  • The 4-year median for Capital Expenditures is $112000.0 (2023), against an average of $617166.7.
  • Year-over-year, Capital Expenditures plummeted 83.33% in 2024 and then soared 9012.5% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $16000.0 in 2023, then skyrocketed by 2225.0% to $372000.0 in 2024, then skyrocketed by 1139.52% to $4.6 million in 2025, then tumbled by 97.22% to $128000.0 in 2026.
  • Per Business Quant, the three most recent readings for KURA's Capital Expenditures are $128000.0 (Q1 2026), $4.6 million (Q4 2025), and $277000.0 (Q3 2025).